41876-72-6

Upstream product

• 1204-86-0 4-(4-morpholinyl)benzaldehyde 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 477941-30-3 3-(4-morpholin-4-yl-phenyl)-prop-2-yn-1-ol 
• 87350-77-4 N-(4-iodophenyl)morpholine 
• 591-50-4 iodobenzene 
• 477941-31-4 (4-morpholin-4-yl-phenyl)-propynal 

Downstream Products

• 59673-45-9 4-[4-(3-piperidin-1-yl-prop-1-ynyl)-phenyl]-morpholine 
• 59673-46-0 4-[4-(3-morpholin-4-yl-prop-1-ynyl)-phenyl]-morpholine 
• 59673-51-7 4-[4-(5-morpholin-4-yl-penta-1,3-diynyl)-phenyl]-morpholine 
• 59673-50-6 4-[4-(5-piperidin-1-yl-penta-1,3-diynyl)-phenyl]-morpholine 
• 58300-72-4 4,4'-(4,4'-butadiynediyl-diphenyl)-bis-morpholine 
• 59673-44-8 diethyl-[3-(4-morpholin-4-yl-phenyl)-prop-2-ynyl]-amine 
• 477941-58-5 1,5-bis-(4-morpholin-4-yl-phenyl)-penta-1,4-diyn-3-ol 
• 937739-74-7 C₃₁H₁₃Cl₁₄NO 
• 1583305-52-5 5-methoxy-2-(4-morpholin-4-yl-phenyl)-1-oxy-indol-3-one 
• 1583305-61-6 4-(4-(5-methoxy-2-nitrophenylethynyl)phenyl)morpholine 
• 477941-59-6 1,5-bis(4-morpholinophenyl)-1,4-pentadiyn-3-one 
• 477941-60-9 Δ-4H-2,6-bis(4-N-morpholinophenyl)selenopyran-4-one 

Relevant academic research and scientific papers

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

The present disclosure relates to compounds, pharmaceutical compositions comprising such compounds, and use of such compounds in methods of treatment or in medicaments for treatment of inflammatory diseases and certain neurological disorders that are related to inflammatory signaling processes, including but not limited to misfolded proteins.

INHIBITORS FOR THE Β-CATENIN / T-CELL FACTOR PROTEIN–PROTEIN INTERACTION

Disclosed are inhibitors for the β-catenin/T-cell factor interaction. The inhibitors are selective for β-catenin/T-cell factor over β-catenin/cadherin and β-catenin/APC interactions. Methods of using the disclosed compounds to treat cancer are also disclosed.

ALKYNYL PHOSPHINE GOLD COMPLEXES FOR TREATING BACTERIAL INFECTIONS

A compound of formula (I) for use in the prevention or treatment of a bacterial infection.

Amino derivatives of indolone-N-oxide: Preparation and antiplasmodial properties

There is an urgent need for new antimalarial drugs with novel mechanisms of action on novel targets. Indolone-N-oxides (INODs) display antimalarial properties in vitro and in vivo, but identified leads such as 6-(4-chloro-phenyl)-5-oxy-[1,3]dioxolo[4,5-f]

First synthesis and electrogenerated chemiluminescence of novel p-substituted phenyl-2-quinolinylethynes

A series of p-substituted phenyl-2-quinolinylethynes as blue-green emitters were synthesized using a modified Sonogashira coupling reaction and their electrogenerated chemiluminescence properties are reported.

In vitro photodynamic properties of chalcogenopyrylium analogues of the thiopyrylium antitumor agent AA1

Several series of chalcogenopyrylium dyes were prepared with one or two 4-anilino substituents at the 2- and 6-positions and with phenyl, 4-N,N-dimethylanilino, or 4-(N-morphilino)phenyl substituents at 2- and/or 4-positions. The dye series are all relate